Dominic Tyer

CSL breaks ground on $1.5bn plasma therapy facility expansion US manufacturing investment forms part of the firm’s efforts to increase its domestic presence and support its supply network.

CSL breaks ground on $1.5 billion expansion of its Illinois facility as it seeks to ramp up US production capacity for its plasma-derived therapies and albumin

www.europeanpharmaceuticalreview.com/news/272063/...

#pharma #manufacturing

The Untold Story of the Birth of the iPhone Apple turns 50 on April 1. In his new book, “Apple: The First 50 Years,” David Pogue chronicles the secrecy-laden environment in which Steve Jobs willed the first iPhone into existence.

It amazes me that we're approaching the 20th anniversary of the birth of smartphone. This extract from David Pogue’s book ‘Apple: The First 50 Years’ sets out the developments and ideas that had to align for the iPhone to come into being. (Outside paywall, I think.)

www.wired.com/story/the-un...

Jacket design for new book The Man Who Broke Reality (US edition).

OK, I have a US jacket design now. I think it looks rather handsome.
The book is published in the autumn, in both the UK (Little Brown) and US (University of Chicago Press).

Posted without comment...

www.usajobs.gov/job/860190200

Cleanroom air quality not impaired by height-adjustable furniture Incorporating ergonomic improvements into pharmaceutical cleanrooms may not negatively impact particle contamination control, new study says.

Cleanroom air quality is not impaired by height-adjustable furniture - that's according to a new study on the effects of incorporating ergonomic improvements into pharmaceutical cleanrooms

www.europeanpharmaceuticalreview.com/news/272041/...

#pharma #cleanroom

Servier deepens oncology focus with $2.5bn Day One acquisition The deal aligns with the biopharma company’s goal of expanding its oncology pipeline by the end of the decade.

Servier acquires Day One for $2.5 billion, deepening its rare cancers commitment

www.europeanpharmaceuticalreview.com/news/272030/...

#pharma

Neuland Laboratories to open Hyderabad commercial peptide facility The CDMO’s Module 1 commercial production module to be operational by summer 2026 as part of its planned phased expansion.

Neuland Laboratories to open Hyderabad commercial peptide facility, with the CDMO’s new commercial production module expected to be operational by summer 2026.

www.europeanpharmaceuticalreview.com/news/272047/...

#pharma #CDMO #CDMOs

Pharmalot: We're reading about a lack of FDA adcomms, FDA loosening biosimilar rules, and more There is growing concern that the FDA is shunning advisory committees that allow agency leaders, drugmakers, patients, and doctors to speak their minds in public

Pharmalot.. Pharmalittle.. We're reading about: We’re reading about a lack of FDA adcomms, FDA loosening biosimilar rules, and more news.. statnews.com/pharmalot/20... #pharma #FDA #biosimilars #novonordisk #Wegovy #weight #obesity #HIMS

CBER chief Vinay Prasad to leave FDA once again For the second time in less than a year, Vinay Prasad has departed from the FDA, after a string of controversial regulatory decisions.

For the second time in less than a year, #VinayPrasad has departed from the #FDA, after #controversial decisions relating to the review of #vaccines and #raredisease therapies.

pharmaphorum.com/news/cber-ch...

Bar chart of responses to the question, 'Which of these new tasks would you be happy to do through the NHS App?' showing that the public supports most of the proposed new uses of the NHS App in England.

Our survey of attitudes to tech and AI in health care reveals three quarters of the public would be happy to use the NHS App for booking hospital appointments (76%), choosing a preferred hospital (73%) and accessing information about procedures (73%).

Explore more findings 👇
https://bit.ly/407xoJG

This week on EPR: Chinese life science collaborations, microbial detection, pharma manufacturing trends Welcome to EPR’s latest LinkedIn newsletter. Each week we share news, analysis and resources from across the biopharma sector, with a focus on the industry’s manufacturing and research work.

Chinese life science collaborations with UCB and Sanofi, microbial detection, pharma manufacturing trends and more feature in the latest issue of our weekly newsletter.

www.linkedin.com/pulse/week-e...

#pharma #biotech #manufacturing

Yellow bird with black face and red eye, all puffed out and slightly damp.

Let me start a belated thread of Aotearoa New Zealand silvan birds.

To lead things off, a New Zealand Bellbird photographed on Kapiti Island.

New York considers bill that would ban chatbots from giving legal, medical advice | StateScoop A bill under consideration in New York would provide a private right of action, allowing people to file lawsuits against chatbot owners who violate the law.

The latest NY chatbot bill would bar chatbots from conveying information that could fall within the scope of a licensed profession.

It’s basically a censorship bill disguised as licensure protection.

statescoop.com/new-york-bil...

The House of Lords Communications and Digital Committee has just published its report 'AI, copyright and the creative industries'. publications.parliament.uk/pa/ld5901/ld...

#BMJResearch: GLP-1 drugs used to treat type 2 diabetes and obesity may also help to lower the risk of addiction to a range of substances including alcohol, cannabis, nicotine, and opioids, finds a large US study

Includes a #VisualAbstract
https://bit.ly/4cpfzgF

This is oddly interesting.
I’m always struck by how many county flags you see in Northumberland (says the owner of some Northumbrian flag cufflinks).

Funding radar: €30M brain health challenge for innovators Denmark’s BioInnovation Institute (BII) is offering a three-year accelerator programme for entrepreneurial researchers who want to spin out their research into therapies for nervous system…

€30M brain health challenge for innovators. Denmark’s BioInnovation Institute seeks projects ready to spin out therapies. Full details:

#womenshistorymonth #Histmed

South Africa seeks local production of Gilead's HIV prevention drug South Africa is asking ​local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, domestically, ‌in a push to bring production to the region where it i...

Via Reuters: www.reuters.com/business/hea...

Please share this around #MedSky. Far too many clinicians are still practicing like it's 2019.

#SciSky #StandUpForScience

A social distancing sign emphasizes maintaining distance for safety, with instructions to stay informed through directional signs.

Relic of a grim time.

Just what we need. Not. Brace brace

The majority of UK academic institutions now no longer post on X - LSE Impact For the first time, more UK universities and associated organisations are inactive on X than active.

💥New post | The majority of UK academic institutions now no longer post on X

✍️ @andytattersall.bsky.social

#AcademicSky #X #AcademicSocialMedia

If you want to know how the British print news industry ends (which is, de facto, amazingly still what supports most newspaper websites) it's the distribution channels getting banjaxed. When you lose "TG Jones" etc even people who want a paper can't get one. That'll be the real start of the ending.

Novo Nordisk expands GLP-1 manufacturing capacity in Ireland Near €500 million investment will increase the firm’s capacity to produce tablet versions of its obesity and diabetes medicines.

Novo Nordisk invests almost €500 million to expand its oral GLP-1 manufacturing capacity in Ireland

www.europeanpharmaceuticalreview.com/news/271739/...

#pharma #manufacturing #GLP1

Love pencils & almost always have one nearby for making deletable notes on manuscripts/books, or for notes/articles/stories

‘Boys’ club’ shutting women out of private hospitals Royal College of Surgeons report highlights stark gender gap in independent hospitals and calls for urgent reform

Just 6 per cent of surgeons in private hospitals are women, says a report warning that a “private boys’ club” culture stops talented female doctors from getting work,writes @eleanorhayward.bsky.social www.thetimes.com/article/04b2...

Charles River Laboratories parts ways with its CDMO business Aims to further strengthen and broaden its portfolio in order to drive long-term growth, greater efficiency and operational excellence.

Charles River Laboratories parts ways with its contract manufacturing business and hatches plans to sell some of its European discovery services

www.europeanpharmaceuticalreview.com/news/271717/...

#pharma #manufacturing #CDMO #CDMOs

Welp...